Monday, April 13, 2026

Pfizer Toxicologist’s Bombshell Testimony Rocks German Parliament : Elon Musk Says Vaccine Dose Left Him ‘Feeling Like Dying

Date:

A recent disclosure by a Swedish journalist on the social media platform X has triggered significant public discourse regarding the safety of COVID-19 vaccines. The journalist reported that a senior official from Pfizer admitted during a testimony to an inquiry commission that approximately 60,000 deaths may be attributable to the vaccine’s side effects. This shocking claim has yet to gain traction in mainstream media, which the journalist accuses of being tightly controlled by influential entities, including networks linked to Bill Gates and the pharmaceutical industry, thereby suppressing crucial information from the public.

Media Silence and Public Reaction

Despite the notable lack of coverage from traditional news outlets, the journalist’s tweet rapidly gained attention, amassing over 25 million views within six hours. This reflects a significant public interest and a burgeoning concern about vaccine safety. The discussion intensified further when Elon Musk shared the post, recounting his own negative experience following vaccination. Musk’s amplification contributed an additional 24 million views, escalating the already heated conversation into a more substantial global debate.

This situation extends beyond a simple public health issue; it raises critical questions about the control of information, narrative manipulation, and the systematic silencing of dissenting views. Such admissions, which have been overlooked by major publishers, call into question the broader implications of how information and public health discourse are managed. The experience of sudden cardiac events in vaccinated younger populations highlights the need for urgent and thorough investigations into the potential side effects of these vaccines.

The alarming patterns of adverse health events linked to COVID-19 vaccinations underscore the urgent need for transparent, independent investigation. The absence of an open dialogue on these pressing concerns has sparked calls for accountability. If pharmaceutical interests and their affiliated networks are influencing the information presented to the public, the implications extend into the realm of moral responsibility. It is suggested that every life lost and every question raised demands thorough scrutiny and action.

The messaging is clear: protecting human life should surpass the interests of profit or reputation. The ramifications of suppressing such critical information can no longer be dismissed as mere ignorance; they represent a profound complicity in the system that prioritizes convenience over truth.

Inquiry Background

Pfizer Toxicologist’s Bombshell Testimony Rocks German Parliament

In March 2026, Germany’s Bundestag hosted a parliamentary inquiry into the safety and efficacy of COVID-19 vaccines, prompted by ongoing public concerns over adverse events and data transparency. Dr. Helmut Sterz, a veteran toxicologist who served as Pfizer’s chief toxicologist for Europe until 2005, emerged as a key witness. His 30+ years at the company gave him insider knowledge of pharmaceutical testing protocols, making his statements particularly weighty.

Dr. Helmut testified that Pfizer’s mRNA vaccine (Comirnaty) bypassed standard toxicology testing required for novel products. He highlighted:

  • Lack of Preclinical Tox Studies: No comprehensive animal trials assessed lipid nanoparticle distribution or long-term toxicity before human rollout. “This was unprecedented,” Sterz stated, comparing it to routine drug development where such tests are mandatory.
  • Batch Variability: Internal data showed huge differences in adverse event rates across vaccine batches—some “hot lots” linked to severe reactions, while others were benign. He called this “a red flag ignored.”
  • Underreported Risks: Pfizer allegedly prioritized speed over safety, with mechanisms like the PREKINE study (a small Phase I trial) insufficient to catch organ accumulation of spike proteins or lipids.

These claims align with whistleblower documents and VAERS data analyses, which Dr. Helmut referenced, noting ratios of severe events up to 12:1 between high- and low-risk batches.

Dr. Helmut accused Pfizer of “scientifically untenable” shortcuts, urging independent batch testing. He criticized the EMA and Paul Ehrlich Institute for rubber-stamping approvals without demanding full tox data. “Patients were guinea pigs,” he said bluntly.

  • Carcinogenicity and Reproductive Toxicity Not Tested:
    • The carcinogenic risk of Comirnaty was not evaluated prior to approval due to time constraints.
    • No alternative studies were conducted to compensate for this omission.
    • A reproductive toxicity study on rats was poorly conducted, yielding unreliable data on effects during pregnancy and fetal development.
  • Accelerated Approval Process:
    • Approval was granted rapidly (“Schnelldurchgang”) according to the Robert Koch Institute (RKI) internal protocols.
    • Essential toxicological studies were sacrificed without valid justification.
    • Dr. Helmut states no comparable vaccine with a similar indication has been approved without these studies.
    • This expedited approval led to what the expert terms “illegal human experiments”.
  • Post-Marketing Safety Surveillance and Mortality Data:
    • Pfizer’s postmarketing report indicated over 1,200 suspected deaths within two months after approval.
    • The Paul Ehrlich Institute (PEI) received 2,133 death reports post-Comirnaty vaccination in Germany, but underreporting is significant.
    • In the U.S., an underreporting factor of about 30 is assumed; applying this to Germany suggests up to 60,000 vaccine-related deaths, though this figure is extrapolated and thus Not specified/Uncertain.
    • The German government withheld key safety and vaccination data from commissions, many of whom declined to request it.
  • Legal and Risk-Benefit Considerations:
    • Many vaccine-injured patients in Germany struggle to obtain compensation; courts often rule that Comirnaty has a positive benefit-risk ratio.
    • Clinical trials did not assess Comirnaty’s ability to prevent severe COVID-19 or death directly.
    • A mathematical estimate suggests that for every severe COVID case prevented, about 25 severe adverse reactions occur.
  • Mortality Trends:
    • Age-adjusted mortality in Germany increased in 2021 and 2022 compared to 2020, contradicting expectations if the vaccine were effective and safe.
  • Vaccine Composition and Manufacturing Concerns:
    • The vaccine tested in clinical trials was a highly purified substance too costly for mass production.
    • The widely distributed vaccine was produced using the bacterium Escherichia coli, resulting in significant contamination with bacterial DNA.
    • This contamination may contribute to a substantially increased cancer risk.

The testimony, livestreamed and widely shared online, has fueled calls for vaccine recalls, lawsuits, and a EU-wide audit. Opposition MPs hailed it as “explosive”.

This fits a pattern of 2026 revelations, including U.S. lawsuits against Pfizer for misrepresenting efficacy (95% claim based on relative risk reduction) and Finnish data showing excess mortality post-vaccination.

The revelations surrounding the possible side effects of the COVID-19 vaccine, alongside the media’s apparent reluctance to cover these stories, urge a reevaluation of the dynamics at play in public health decision-making. The public’s demand for truth and answers is rising, indicating a crucial moment in which ordinary citizens are seeking more transparent discourse regarding vaccine safety. It is imperative that stakeholders—governments, pharmaceutical companies, and media organizations—be held accountable for the information shared, as collective human life and wellbeing are at stake.

Also read:

Genetic Apocalypse: Pfizer’s mRNA Deception and the Threat to Humanity

The Trovan Case in Nigeria: Ethical Violations, Consequences, and Lessons Learned with Pfizer’s Experimental Drug

Landmark First Peer-Reviewed Study on Pfizer and Moderna Covid Vaccines Confirms ‘Excess Risk’ of Adverse Side Effects – Becker News

BREAKING: January 26, 2023, suggest that Pfizer is currently mutating COVID variants in order to produce vaccines for future sale.

Pfizer Caught Funnelling $12 Million to Anderson Cooper To Promote mRNA Jabs to Americans

Pfizer is sued by Texas over COVID-19 vaccine claims

Government Documents prove Bill Gates is Primary Funder of UK Medicine Regulator despite owning huge shares in Pfizer

 

Dr. Naomi Wolf Uncovers Pfizer’s Depopulation Agenda, as Evidenced by Its Own Documents

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

PM Modi’s Politics of salutation

Yesterday, an interesting photo and video emerged from the Parliament House complex and became the subject of discussion...

rump’s anger erupts when agreement fails in Pakistan

Talks held in Islamabad, Pakistan, on Saturday (April 11, 2026) to stop the ongoing war between Israel, the...

SIR Anti-Unity Movement Pushes to Cancel Campaigning After Massive Voter Exclusion: “Either Voting Rights or Voluntary Death”

An urgent press conference at the Kolkata Press Club highlighted a serious issue in West Bengal concerning voting...

Big news of the moment

Patna: Nitish government's major decision Banned private practice by government doctors Government doctors will no longer be able to practice...
news-1701

sabung ayam online

yakinjp

yakinjp

rtp yakinjp

slot thailand

yakinjp

yakinjp

yakin jp

yakinjp id

maujp

maujp

maujp

maujp

sabung ayam online

sabung ayam online

judi bola online

sabung ayam online

judi bola online

slot mahjong ways

slot mahjong

sabung ayam online

judi bola

live casino

sabung ayam online

judi bola

live casino

SGP Pools

slot mahjong

sabung ayam online

slot mahjong

SLOT THAILAND

berita 128000726

berita 128000727

berita 128000728

berita 128000729

berita 128000730

berita 128000731

berita 128000732

berita 128000733

berita 128000734

berita 128000735

berita 128000736

berita 128000737

berita 128000738

berita 128000739

berita 128000740

berita 128000741

berita 128000742

berita 128000743

berita 128000744

berita 128000745

berita 128000746

berita 128000747

berita 128000748

berita 128000749

berita 128000750

berita 128000751

berita 128000752

berita 128000753

berita 128000754

berita 128000755

artikel 128000821

artikel 128000822

artikel 128000823

artikel 128000824

artikel 128000825

artikel 128000826

artikel 128000827

artikel 128000828

artikel 128000829

artikel 128000830

artikel 128000831

artikel 128000832

artikel 128000833

artikel 128000834

artikel 128000835

artikel 128000836

artikel 128000837

artikel 128000838

artikel 128000839

artikel 128000840

artikel 128000841

artikel 128000842

artikel 128000843

artikel 128000844

artikel 128000845

artikel 128000846

artikel 128000847

artikel 128000848

artikel 128000849

artikel 128000850

article 138000756

article 138000757

article 138000758

article 138000759

article 138000760

article 138000761

article 138000762

article 138000763

article 138000764

article 138000765

article 138000766

article 138000767

article 138000768

article 138000769

article 138000770

article 138000771

article 138000772

article 138000773

article 138000774

article 138000775

article 138000776

article 138000777

article 138000778

article 138000779

article 138000780

article 138000781

article 138000782

article 138000783

article 138000784

article 138000785

article 138000816

article 138000817

article 138000818

article 138000819

article 138000820

article 138000821

article 138000822

article 138000823

article 138000824

article 138000825

article 138000826

article 138000827

article 138000828

article 138000829

article 138000830

article 138000831

article 138000832

article 138000833

article 138000834

article 138000835

article 138000836

article 138000837

article 138000838

article 138000839

article 138000840

article 138000841

article 138000842

article 138000843

article 138000844

article 138000845

article 138000786

article 138000787

article 138000788

article 138000789

article 138000790

article 138000791

article 138000792

article 138000793

article 138000794

article 138000795

article 138000796

article 138000797

article 138000798

article 138000799

article 138000800

article 138000801

article 138000802

article 138000803

article 138000804

article 138000805

article 138000806

article 138000807

article 138000808

article 138000809

article 138000810

article 138000811

article 138000812

article 138000813

article 138000814

article 138000815

story 138000816

story 138000817

story 138000818

story 138000819

story 138000820

story 138000821

story 138000822

story 138000823

story 138000824

story 138000825

story 138000826

story 138000827

story 138000828

story 138000829

story 138000830

story 138000831

story 138000832

story 138000833

story 138000834

story 138000835

story 138000836

story 138000837

story 138000838

story 138000839

story 138000840

story 138000841

story 138000842

story 138000843

story 138000844

story 138000845

article 138000726

article 138000727

article 138000728

article 138000729

article 138000730

article 138000731

article 138000732

article 138000733

article 138000734

article 138000735

article 138000736

article 138000737

article 138000738

article 138000739

article 138000740

article 138000741

article 138000742

article 138000743

article 138000744

article 138000745

article 208000456

article 208000457

article 208000458

article 208000459

article 208000460

article 208000461

article 208000462

article 208000463

article 208000464

article 208000465

article 208000466

article 208000467

article 208000468

article 208000469

article 208000470

journal-228000376

journal-228000377

journal-228000378

journal-228000379

journal-228000380

journal-228000381

journal-228000382

journal-228000383

journal-228000384

journal-228000385

journal-228000386

journal-228000387

journal-228000388

journal-228000389

journal-228000390

journal-228000391

journal-228000392

journal-228000393

journal-228000394

journal-228000395

journal-228000396

journal-228000397

journal-228000398

journal-228000399

journal-228000400

journal-228000401

journal-228000402

journal-228000403

journal-228000404

journal-228000405

article 228000376

article 228000377

article 228000378

article 228000379

article 228000380

article 228000381

article 228000382

article 228000383

article 228000384

article 228000385

article 228000386

article 228000387

article 228000388

article 228000389

article 228000390

article 228000391

article 228000392

article 228000393

article 228000394

article 228000395

article 228000396

article 228000397

article 228000398

article 228000399

article 228000400

article 228000401

article 228000402

article 228000403

article 228000404

article 228000405

article 228000406

article 228000407

article 228000408

article 228000409

article 228000410

article 228000411

article 228000412

article 228000413

article 228000414

article 228000415

article 228000416

article 228000417

article 228000418

article 228000419

article 228000420

article 228000421

article 228000422

article 228000423

article 228000424

article 228000425

article 228000426

article 228000427

article 228000428

article 228000429

article 228000430

article 228000431

article 228000432

article 228000433

article 228000434

article 228000435

article 238000461

article 238000462

article 238000463

article 238000464

article 238000465

article 238000466

article 238000467

article 238000468

article 238000469

article 238000470

article 238000471

article 238000472

article 238000473

article 238000474

article 238000475

article 238000476

article 238000477

article 238000478

article 238000479

article 238000480

article 238000481

article 238000482

article 238000483

article 238000484

article 238000485

article 238000486

article 238000487

article 238000488

article 238000489

article 238000490

article 238000491

article 238000492

article 238000493

article 238000494

article 238000495

article 238000496

article 238000497

article 238000498

article 238000499

article 238000500

article 238000501

article 238000502

article 238000503

article 238000504

article 238000505

article 238000506

article 238000507

article 238000508

article 238000509

article 238000510

article 238000511

article 238000512

article 238000513

article 238000514

article 238000515

article 238000516

article 238000517

article 238000518

article 238000519

article 238000520

update 238000492

update 238000493

update 238000494

update 238000495

update 238000496

update 238000497

update 238000498

update 238000499

update 238000500

update 238000501

update 238000502

update 238000503

update 238000504

update 238000505

update 238000506

update 238000507

update 238000508

update 238000509

update 238000510

update 238000511

update 238000512

update 238000513

update 238000514

update 238000515

update 238000516

update 238000517

update 238000518

update 238000519

update 238000520

update 238000521

sumbar-238000396

sumbar-238000397

sumbar-238000398

sumbar-238000399

sumbar-238000400

sumbar-238000401

sumbar-238000402

sumbar-238000403

sumbar-238000404

sumbar-238000405

sumbar-238000406

sumbar-238000407

sumbar-238000408

sumbar-238000409

sumbar-238000410

news-1701